Arctic Bioscience AS (ABS.OL)

NOK 4.6

(-12.21%)

Total Debt Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual total debt in 2023 was 2.04 Million NOK , up 86.82% from previous year.
  • Arctic Bioscience AS's latest quarterly total debt in 2023 FY was 2.04 Million NOK , up 86.82% from previous quarter.
  • Arctic Bioscience AS reported annual total debt of 1.09 Million NOK in 2022, up 26103.56% from previous year.
  • Arctic Bioscience AS reported annual total debt of 4185.00 NOK in 2021, down -99.95% from previous year.
  • Arctic Bioscience AS reported quarterly total debt of - NOK for 2023 Q1, down -100.0% from previous quarter.
  • Arctic Bioscience AS reported quarterly total debt of 5.57 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Total Debt of Arctic Bioscience AS (2023 - 2018)

Year Total Debt Total Debt Growth
2023 2.04 Million NOK 86.82%
2022 1.09 Million NOK 26103.56%
2021 4185.00 NOK -99.95%
2020 8.45 Million NOK 18.12%
2019 7.15 Million NOK -40.66%
2018 12.06 Million NOK 0.0%

Peer Total Debt Comparison of Arctic Bioscience AS

Name Total Debt Total Debt Difference
Aqua Bio Technology ASA 7.12 Million NOK 71.239%
ArcticZymes Technologies ASA 12.58 Million NOK 83.726%
BerGenBio ASA 418 Thousand NOK -390.127%
Hofseth BioCare ASA 136.78 Million NOK 98.502%
PCI Biotech Holding ASA 319 Thousand NOK -542.235%
Thor Medical ASA - NOK -Infinity%
Ultimovacs ASA 3.71 Million NOK 44.823%